Objective: The study aimed to characterize the lipid and apolipoprotein profile and the prevalence of cardiovascular risk factors in a population of urban adult women of Morocco. Design: A total of 213 women 25-55 y old were sampled from an agricultural province of Morocco: El Jadida. The following parameters of lipid and apolipoprotein profile were measured: plasma triglycerides (TG), plasma cholesterol (TC), triglyceriderich lipoprotein triglycerides (TRL-TG), TRL-cholesterol (TRL-C), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and apolipoproteins A1, B, B48, CIII and E. Waist circumference (WC), body mass index (BMI) and blood pressure (BP) were also determined. Results: The women studied showed the following pattern: elevated TC, LDL-C levels and TC/HDL-C in 10, 19.4 and in 43.8%, respectively; low HDL-C levels in 45.3% (o0.9 mmol/l) or in 95% (when the cutoff o1.3 mmol/l is used), elevated TG levels in 11.8%. Elevated TRL-C (40.6 mmol/l) and TRL-TG (40.8 mmol/l) were observed in 13.4%. Obesity and hypertension were highly prevalent in 23.9 and 16.5%, respectively. Plasma triglyceride concentrations were closely correlated with plasma concentrations of TRL-TG (R ¼ 0.86, P ¼ 0.0001), apoB (R ¼ 0.50, P ¼ 0.0001) and apoCIII (R ¼ 0.52, P ¼ 0.0001) and moderately correlated with HDL-C levels (R ¼ À0.3, P ¼ 0.0001) and BMI (R ¼ 0.4, P ¼ 0.0001). The association between BMI and systolic blood pressure was statistically significant (R ¼ 0.3, P ¼ 0.0001). Obesity, BP, TRL-C, TRL-TG, TG, apoB and apoCIII increased with age. Conclusion: There is a high prevalence of some risk factors for cardiovascular disease including altered lipid and lipoprotein profiles in the Moroccan urban women studied, some of these risk factors are associated with age.
Introduction
Cardiovascular disease (CVD) is one of the most important public health problems in developed countries. In most industrialized countries this group of diseases, with ischemic cardiopathy and coronary disease in the foreground, has become a major cause of death over the last decades (WHO, 1997) . Although incidence of mortality from coronary disease recently decreased in Western Europe, in North America and Australia, there is an alarming increase of coronary disease in central and Eastern Europe (Sans et al, 1997) .
In Africa where a short life expectancy in relation to infections and malnutrition is the rule, appearance of some cardiovascular risk factors, like smoking, hypertension, altered lipid profile and the metabolic syndrome associated to central obesity can account for the increase in cardiovascular morbidity and mortality (Chaturvedi et al, 1996; Luke et al, 2001) .
Epidemiological studies of populations in their natural environment, with several years follow-up, have identified certain characteristics and personal habits strongly related to the probability of the onset of CVD. These factors have generically been called risk factors and may or may not be amenable to intervention. Among the former are smoking (PDAY, 1990) , lack of physical activity (Shaw, 1981) , diet (Woo et al, 1993; Bao et al, 1995) , hypertension (Kannel, 1975) , hypercholesterolemia (Stamler et al, 1986) , glucose intolerance (Fuller et al, 1980; Jeffery et al, 1992) and obesity (Hubert et al, 1983; Jeffery et al, 1992) . Factors nonamenable to control are aging (NCHS, 1991) , sex (male) (Bush, 1996) and heredity (Barrett-Connor & Khaw, 1984) .
In Morocco, a growing extension of chronic diseases can result from the recent environmental and behavioural changes such as the adoption of new dietary habits, sedentarity or stress linked to urbanization and work conditions. Nevertheless, until now, there are no data available at the population level on the CVD risk profile in Moroccan women. Obesity and type 2 diabetes are already known to be prevalent in Moroccan women over 30 y (Mokhtar et al, 1997; Chabir et al, 1998) . A regional crosssectional survey undertaken before on childbearing age women showed a high prevalence of overweight and obesity after 30 y (Belahsen et al, 2004) , but no study describing lipid or lipoprotein pattern are available.
In this work, we aimed to study for the first time the lipid, lipoprotein and apolipoprotein profile, and to determine the prevalence of some cardiovascular risk factors in a population of women aged 25-55 y, living in urban area of El jadida, an agricultural province of Morocco and mostly affected by malnutrition, illiteracy and socio-economic problems.
Methods

Subjects
The study was performed between September and December 2000 on subjects aged 25-55 y. A total of 213 urban adult women volunteers 25-55 y old, not pregnant, living in the province of El jadida, in the northwest of Morocco were randomly selected from 263 volunteers who visited public health centers during a campaign of immunization. Nine subjects who were postmenopausal, 12 subjects who were insulin or blood pressure (BP)-treated and 29 subjects with incomplete data collection were excluded.
The recruitment was made according to the women age, based on the data of a cross-sectional survey realized before in the region of El Jadida in 1995, on women at childbearing age (15-49 y) and showing that the CVD risk factors were more prevalent in women of around 30 y old. The final study sample size was 213 women of appropriate age. Randomly, the study sample included factory workers (85% of women) and teachers (15% of women). There were no smokers among the women participating to this investigation.
For some analyses, women were divided into three groups of age: 25-34, 35-44 and 45-55 . Body weight, height and waist circumference (WC) were measured in all subjects wearing only light underwear and no shoes. The body mass index (BMI) was calculated as weight divided by square height (kg/m 2 ). WHO definition for overweight (25rBMIo30) and obesity (BMIZ30 kg/m 2 ) was used (WHO, 1995) .
The study protocol has been accepted by the dedicated Moroccan authority of ministry of health. Each participant gave a written consent.
Analytical determinations
Blood samples were collected into vacutainer tubes containing disodium EDTA after a 10-12 h overnight fast. Plasma was immediately separated from whole blood by centrifugation (910 Â g at 101C for 10 min) and added with proteolysis inhibitors. The plasma samples were stored at À901 until measurements. All measurements were performed belonging to ARCOL (Association for Research on Cholesterol and Lipoproteins).
Plasma cholesterol (TC) and triglycerides (TG) concentrations were determined by enzymatic procedure with commercial kits (Biomérieux) (Allain et al, 1974; Fossati & Prencipe, 1982) . Plasma levels of high-density lipoprotein cholesterol (HDL-C) were measured with commercial kits (direct HDL-cholesterol, Randox) (Sugiuchi et al, 1995; Harris et al, 1996) and concentration of low-density lipoprotein cholesterol (LDL-C) were calculated using the Friedewald formula (Friedewald et al, 1972) . Lipid and lipoprotein values were expressed as mmol/l. Hypercholesterolemia was defined as mild for cholesterol values in the range 5.2-6.2 mmol/l and moderate to severe for cholesterol values 46.2 mmol/l. Hypo-HDL cholesterolemia was defined for values lower than 0.9 or 1.3 mmol/l and hypertrigyceridemia was defined for values higher than 1.4 mmol/l (ANAES, 2000; NCEP, 2001) . As there are no Moroccan norms for lipid and lipoprotein levels, the European standards were used.
The triglyceride-rich lipoprotein (TRL) fraction (VLDL and chylomicrons and their remnants) was isolated from 1.5 ml plasma layered under 1.5 ml KBr (d ¼ 1006) by ultracentrifugation at 151C (540 960 Â g for 2 h 40 min) using a Beckman TLX100 ultracentrifuge and a 100.3 rotor, as previously described (Brousseau et al 1993) . TG and total cholesterol were assayed in TRL fractions by enzymatic procedure with commercial kits, as described above.
Plasma apolipoproteins AI (Fievet-Desreumaux et al, 1980), B (Fievet-Desreumaux et al, 1979) and E (Labeur et al, 1990) were measured by nephelometry (Dade Behring Nephelometer, Dade Behring Marburg, Germany). Assessment of plasma apoB48 (a truncated form of apoB100 specifically secreted by the human small intestine (Hussain et al, 1996) was performed by competitive enzyme-linked immunosorbent assay (ELISA) with a specific antiapoB48 antibody according to Lorec et al (2000) .
ApoCIII concentrations were determined by electroimmunoassay method using Hydragel LpC-III kit purchased from Sebia (Issy-les-Moulineaux, France) (Alsayed et al, 1990) .
BP was evaluated using a mechanical BP machine (Trim line LIC) after a rest period of at least 10 min.
Statistical analysis
Statistical calculations, including linear regression analysis, were performed with SPSS/PC statistical software package (SPSS Inc., Chicago, IL, USA). Values were expressed as mean7s.d. Analysis of variance was used to analyse differences of anthropometrical and plasma parameters among the different groups, after testing for normality of distribution of the compared variables. Differences among subgroups were identified by the Scheffe test. P-values o0.05 were considered statistically significant.
Results
Subject characteristics
The population studied was composed of women 25-55 y old, living in the urban area of El jadida province of Morocco. Among the 213 women studied, 61 (28,6%) were aged between 25 and 34, 55 (25.8%) 35-44 and 97 (45.5%) 45-55 y. The mean age was 40.678.6 y. The mean plasma total cholesterol, HDL-cholesterol, LDL-cholesterol, TC/HDL-C and TG concentrations were 4.0470.71, 0.9470.21, 2.6770.69, 4.4871.33 and 0.8970.42 mmol/l, respectively. The prevalence of hyperlipidemia was moderately high. In total, 10% of the women sample had elevated plasma cholesterol (TC45.2 mmol/l), 95% had low HDL-C (HDL-Co1.3 mmol/l), 19.4% had elevated LDL-C (LDL-C43.4 mmol/l), 43.8% had high TC/HDL-C (TC/HDL-C45) and 11.8% had high TG (41.4 mmol/l).
Mean plasma TRL-TG and TRL-C were 0.6070.43 and 0.3470.29 mmol/l, respectively. The mean concentrations and the prevalence of abnormal levels of the apolipoproteins determined in plasma were, respectively, 1.3970.23 and 20% (below 1.2 g/l) for apoAI, 0.8970.22 and 28.9% (above 1.0 g/l) for apoB, 0.0570.08 with 27.7% (above 0.05 g/l) for apoB48, 0.0270.006 with 22.1% (above 0.025 g/l) for apoCIII and 0.03970.01 and 15.0% ( above 0.05 g/l) for apoE.
Several regression analyses were performed. The main results showed that plasma triglyceride concentrations were closely correlated with plasma TRL-TG (R ¼ 0.86, P ¼ 0.0001), apoB (R ¼ 0.50, P ¼ 0.0001) and apoCIII (R ¼ 0.52, P ¼ 0.0001) concentrations and to a lesser degree correlated with levels of HDL-C (R ¼ À0.3, P ¼ 0.0006) and BMI (R ¼ 0.4, P ¼ 0.0001).
The correlation between BMI and SBP was statistically significant (R ¼ 0.3, P ¼ 0.0001).
Variation of cardiovascular risk factors with age, BMI and BP Mean (7s.e.) values and prevalence of abnormal WC, BMI, BP and serum lipids and apoplipoproteins, according to the three different age categories (25-34, 35-44 and 45-55) , are given in Figure 1 and Table 2 . BMI (P ¼ 0.0001), DBP (P ¼ 0.0001), TRL-C (P ¼ 0.0003), TRL-TG (0.0005), TG (P ¼ 0.0001), apoB (P ¼ 0.0001) and apoCIII (P ¼ 0.0003) were 
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M El ayachi et al significantly higher in the medium (35-44 y) and older (45-55 y) than in the younger age groups (25-34 y). Conversely, there were no significant differences between the medium and older groups for these parameters. No differences were found between age groups for TC, LDL-C, HDL-C, TC/HDL-C, apoA1, apoB48 and apoE. SBP was significantly higher in the older group than in the younger (P ¼ 0.0001) and the medium groups (P ¼ 0.0001), but no significant difference was found between the younger and the medium groups.
The prevalence of abnormal values of these parameters according to BMI and BP varied almost similarly to that observed according to the age groups (Table 2) .
Discussion
The focus of this population-based study was to evaluate the profile and the prevalence of risk factors of CVD among urban Moroccan adult women (aged 25-55 y). The study results show a high prevalence of some risk factors for CVD as well as an association between these factors and altered lipid profile in this population. To our knowledge, the present study provides one of the first epidemiological information on the lipoprotein profile and prevalence of the metabolic risk factors for CVD such as obesity, BP and metabolic lipid related risk factors in a Moroccan urban women.
The results warn on the problem of chronic disease and the necessity of intervention to prevent them. The prevalence of these factors was found to be comparable and even higher than in some western countries.
Obesity, as a recognised risk factor for CVD (Assmann et al, 1997) , was widely prevalent among this urban population of women (24%), which is somewhat higher than the figures obtained in matched European subjects (ERICA Research Group, 1988) (8%) and comparable to that reported in women from Tunisia (27.7%) another North African country (Ghannem & Hadj Fredj, 1997) .
Also the prevalence of hypertension was comparable to that found in Tunisian (Ghannem & Hadj Fredj, 1997) as well as to that reported in the western population in Quebec, Canada (Santé Québec, 1990; Lapierre & Couture, 1995) where the same approach was used.
The lipid concentrations found here are comparable to those reported in normal subjects in Algeria (MedieneBenchekor et al, 2001) . Abnormalities in serum lipids, lipoproteins and apolipoproteins, especially lower levels of HDL-C and higher levels of serum LDL-C and TG are generally accepted as independent risk factors for CVD (Wood et al, 1998; Gotto et al, 2000; Pascot et al, 2002) . The prevalence of hypercholesterolemia and hyper-LDL cholesterolemia in this population was lower than in subjects from developed countries. Conversely, the prevalence of hypo-HDL cholesterolemia and hypertriglyceridemia was higher than that found in some developed countries (Dubois, 1991; Connelly et al, 1992; Cambou et al, 1996; Von Hafe et al, 1998) .
The abnormal plasma levels of some apolipoproteins have been considered as independent risk factors for CVD. Several studies have shown that apoB is a marker of atherogenic particles, mainly LDL (Schaefer et al, 1994; Westerveld et al, 1998) , but also VLDL, IDL, and lipoprotein (a) (Connelly et al, 1992; Gotto et al, 2000) , whereas apoA1 is a marker of antiatherogenic particles, such as HDLs (O'Brien et al, 1995; Francis & Frohlich, 2001 ). ApoB and apoAI could improve the prediction of risk of coronary artery disease (Walldius et al, 2001) . Evaluation of plasma apolipoprotein parameters WC (485 cm showed a high prevalence of low apoA1 in 20% and elevated apoB in 28.9% of women in this population. In addition, apoCIII and apoE are proteins that play a central role in controlling metabolism of TRL. In normolipidemic subjects, the majority of apoCIII (inhibitor of lipoprotein lipase) is bound to HDL, while in hypertriglyceridemic subjects, the majority is bound to TRL (Schonfeld et al, 1979; Fredenrich et al, 1997) . ApoE plays a pivotal role in mediating the hepatic recognition and uptake of TRL by serving as ligand for lipoprotein binding to the LDL-R (Mahley & Huang, 1999) . In this population of urban women, the prevalence of elevated apoCIII and apoE was 22.1 and 15%, respectively. Elevated fasting apoCIII levels have been associated to defective lipid clearance in women (Mekki et al, 1999) . The main results reported here showed that plasma triglyceride concentrations were closely correlated with plasma TRL-TG, apoB and apoCIII as well as with levels of HDL-C and BMI.
A high prevalence of some risk factors for CVD was observed in the women aged 35-55 y.
Increased age was associated with abnormality in some lipid and apoliprotein profiles as well as in anthropometrical parameters. High BP and obesity were also accompanied with altered lipid and lipoprotein profile. These results show that all these parameters could be involved in the alteration of the lipid and lipoprotein profile observed in this population. In addition, our results showed for the first time that some risk factors for CVD appeared early before menopause in this women group. However, no hormones status was investigated here.
The study showed that the Moroccan urban population of women exhibited important cardiovascular risk factors, which are not far from those found in western societies. The evaluation of cardiovascular risk factors in a developing country such as Morocco appears therefore of great interest. As no previous data are available, it is unfortunately not possible to evaluate possible changes in these risk factors during the last decades. It is generally thought that risk for CVD is much less important in developing countries than industrialized countries due to several traits of lifestyle (unbalanced diet and sedentarity in industrialized countries). Nevertheless, in developing countries, recent urbanization is expected to increase the level of cardiovascular risk factors as a result of the adoption of new dietary habits and increased sedentarity and stress in urban areas. The data obtained from the present study do point out that a high prevalence of some cardiovascular risk factors can be found in the urban population of Moroccan women aged 35-55 y. To reverse this picture, the adoption of preventive measures has been shown to be more efficient than any form of therapeutic intervention (Lenfant & Savage, 1995) . In line of the present study, increased knowledge of the prevalence of the various risk factors for CVD in populations and among different age groups is essential for effective prevention planning. In fact, there is still an obvious lack of valid data on prevalence of cardiovascular risk factors in Moroccan women, without any national reference data for the percentile distribution of the main cardiovascular risk factors. Data as provided herein will help health officials adopt a national strategy to prevent the extension of cardiovascular risk factors in the population and could serve as a baseline for assessment of future trends in the risk factors studied. As atherosclerosis is an ongoing process and considering that 65% of the present population is under the age of 35 in this country, one would expect the magnitude of CVD to increase markedly in the near future with the increasing exposure to metabolic and nonmetabolic risk factors.
Both environmental and genetical factors play a role in determining lipid and lipoprotein plasma levels, as key factors in the development of CVD (Slack, 1969; Breslow, 1988; Davignon et al, 1988; Santamarina-Fojo, 1992; Ordovas et al, 1995) . Thus, a careful evaluation of dietary habits and physical activity in such a population will provide new insights in the possible role of recent and marked changes in dietary patterns and lifestyle. Moreover, determination of frequency of gene polymorphisms of key proteins involved in lipoprotein metabolism would provide some basic information on the genetic susceptibility of this population. Such evaluations are in progress.
